Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.6543
-0.0061 (-0.92%)
At close: Dec 26, 2025, 4:00 PM EST
0.6601
+0.0058 (0.89%)
After-hours: Dec 26, 2025, 7:40 PM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $31.76 million as of December 26, 2025. Its market cap has decreased by -61.68% in one year.
Market Cap
31.76M
Enterprise Value
3.35M
1-Year Change
-61.68%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $31.76M, a decrease of -92.79%. That is a compound annual growth rate of -43.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 31.76M | -51.85% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |